RxDoctor Payments Data

Denali Vena Cava Filter: payments to doctors

Payments that named Denali Vena Cava Filter as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Was your doctor paid by C. R. Bard, Inc. & Subsidiaries?

C. R. Bard, Inc. & Subsidiaries reported the most payments naming Denali Vena Cava Filter. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$66K
Providers
492
Transactions
658
Average per transaction
$100

The per-transaction average — $100 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 492 providers the average total is $134, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
C. R. Bard, Inc. & Subsidiaries$40,34561.1%
Bard Peripheral Vascular, Inc.$21,52732.6%
BD$4,0216.1%
Davol Inc.$1540.2%

Other products from C. R. Bard, Inc. & Subsidiaries

The company that reported the most payments naming Denali Vena Cava Filter also reports against these.

← All drugs & devices